2013 Archived Content
DISCOVERY ON TARGET 2013
Pharma’s leading targeting event delivers record attendance: 30% growth over 2012
Next Event to Take Place October 8-10, 2014 in Boston
Discovery on Target would like to thank the 800+ speakers, attendees, sponsors and exhibitors who came to Boston for this year’s annual event. The event drew a record number of attendees from 24 countries networking and discussing current and emerging ‘hot’ drug targets for the pharmaceutical industry.
Highlights of this year’s Discovery on Target include:
- 150+ scientific presentations and 175+ speakers across 12 conference tracks and 10 short courses
- New Tracks:
- Targeting Epigenetic Readers
- Antibodies Against Membrane Protein Targets
- Targeting Histone Demethylases
- Functional Genomics Screening Strategies
- GPCR-Targeted Therapeutics
- Cardio-Metabolic Drug Targets
- Exhibit hall of 30+ companies with novel technologies and solutions
- 40+ posters featuring cutting edge research from current and up-and-coming scientists and industry professionals
- Poster Award Winner: Identification of Small Molecule Inhibitors for the Histone Lysine Demethylase JARID1AJoyce Sayegh; Jian Cao; Michael Norcia; Denton Hoyer; Jane S. Merkel; Qin Yan; and Molly Gale from Yale University
- Student Fellowship Program offered to full time graduate students and Ph.D. candidates
- New plenary keynote program – a first for Discovery on Target. Two hugely talented scientists presented critical research and innovating approaches they are making in drug discovery. The first speaker was Stuart Schreiber, Director of Chemical Biology and Founding Member, Broad Institute of Harvard and MIT and Morris Loeb Professor of Chemistry and Chemical Biology at Harvard University. Stuart talked about how advances in human biology are now accelerating patient-based drug discovery. The second keynote presenter was Paul Feldman, Senior Vice President at GlaxoSmithKline. Paul spoke about enteroendocrine drug discovery for the treatment of metabolic diseases.
Save the date!
Next year’s Discovery on Target will be held in Boston on October 8-10, 2014 in Boston
Missed the event?
Order the event proceedings. Although, we can’t make up for the networking and face-to-face discussions, we do offer conference proceedings on CD. Order the entire event proceedings now available on CD! Click here to place your order.
Also, you can also some of news by visiting live tweets that were posted from the event - #DOTBoston13.
Interested in speaking, sponsoring, or exhibiting in 2014?
We will soon begin working on the program agenda for 2014. If you are interested in speaking, please contact Cindy Crowninshield, RDN, LDN, Conference Director, at firstname.lastname@example.org.
To secure a sponsorship or exhibit package for 2014, contact Jon Stroup, Business Development Manager at email@example.com.
Hear what attendees have said about this year’s event!
I was very impressed by the new conference program focusing on generating and characterizing Abs to membrane protein targets. This is a great forum and I will certainly plan to attend next time around.BBC, LLC
The Discovery on Target event is a great place to meet with thought leaders in the field and to discuss the state of the art in both formal and informal settings. There is a perfect balance of information coming from industry and academia that places everything in a mutually believable and applicable context."
Market Segment Manager, Functional Genomics, Sigma Life Science
The Functional Genomics Screening conference was a wonderful opportunity to interact with key opinion-leaders and truly uncover unmet needs in their workflow.
Leading Technology Provider and Sponsor
The RNAi meeting is a great place to learn about new screening technologies and to interact with screening center directors from around the world.
Brent Cochran, GBM Stem Cell Screens
Great organization, venue, speakers, and city. Not too big, not too small, it’s just right. Wide-range of topics that will equip you for drug discovery.
I liked the speed networking session on your program that opened on your agenda. It was a creative productive use of time once we started talking with each other. It was hard to stop. You should do it again. A highly informative meeting, too.
What I love about your meetings, besides the excellent talks, is that one has a chance to really meet and talk to luminaries in the field. At a big society meeting, you usually can’t get within a 20 foot radius of them.
Bristol Myers Squibb
This was a really great meeting. I learned a lot about an area my work is moving into, which is allosteric kinase inhibitors. Thank you for putting this together
Bristol Myers Squibb
It was great to network with the other speakers and the audience. I thought the session was well organized, the topics were relevant, and the discussions were insightful.
Thank you very much for the very dynamic and informative meeting and the opportunity to present our work. I did enjoy both days of the conference including panel and roundtable discussions. Also, I think it was just the right balance between GPCR drug discovery and joined sessions. Thank you and looking forward to future Discovery on Target events.
The Scripps Research Institute
The meeting was a great occasion full of tremendous opportunities to learn, interact with expertise from different areas, as well as network. I really felt that [I was] coming back home with a lot [of] gains.
Janssen Research & Development, LLC
It was a pleasure to participate and many thanks again for giving me the opportunity. I think it was an absolutely fantastic conference, one of the highest quality that I have attended in the past several years.
Research Advisor, Computational Chemistry, Eli Lilly
Thank you for organizing a great conference. It was very informative.
Dir., Structural Bio., Receptos
Thanks for inviting me to participate. It was an excellent event with some good speakers, especially in the afternoon session I got to chair.
VP, Receptor Pharmacology, Array
I enjoyed the meeting. I received enthusiastic feedback from the audiences after my talk.
Associate Professor of Medicine, Harvard Medical School
Thanks again to your organization. Covered the landscape nicely.
CEO, Madrigal Pharmaceuticals
I really enjoyed the conference and heard several people say the same thing. It was perceived by me and others to be a unique and timely subject matter. I felt the talks were well-prepared and on-point, and people showed a lot of good data which was great to see. Everything stayed on time and there were no lulls in activity.
It has been a valuable conference to me with a very good program, the quality of the presentations has in general been excellent. It was good to see that speakers presented novel work besides work that had been published.
Thank you for including me in the meeting on Antibodies Against Membrane Protein Targets. I was impressed with the quality of the talks and made some good contacts. The setting was excellent. I received some very good feedback on my presentation and look forward to following up with some of the people who contacted me after my talk.
Thank you for the opportunity to participate in today’s meeting. I thoroughly enjoyed both the presentation and the roundtable discussion. I thought you did a nice job generating a well rounded, relevant set of speakers. Well done. I look forward to attending this series in the future.
Many thanks to you and your associates for organizing an excellent program for the Antibodies targeting Membrane Proteins component for Discovery on Target. It was a very enjoyable event with great discussions.
Thanks for organizing another fabulous meeting. The new antibodies track seemed to work very well.
I thought the conference was very good—well organized, a good mix of academic and industrial speakers, and the topics were very relevant. I would definitely recommend it to others interested in this area of research.